Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: Systematic review and meta-analysis

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 9, 2012, Pages 1645-1658

  Zoerle, Tommaso ^a   Ilodigwe, Don C ^a   Wan, Hoyee ^a   Lakovic, Katarina ^b   Sabri, Mohammed ^b   Ai, Jinglu ^a   MacDonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

animal model; pharmacologic reduction; subarachnoid hemorrhage; translation; vasospasm

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; CLAZOSENTAN; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; NICARDIPINE; NIMODIPINE; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD PRESSURE; BODY TEMPERATURE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CARBON DIOXIDE MEASUREMENT; CISTERNA MAGNA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRANIOTOMY; DISEASE SEVERITY; EXPERIMENTAL DOG; EXPERIMENTAL MONKEY; EXPERIMENTAL RABBIT; HEART RATE; HISTOLOGY; HUMAN; INTRACRANIAL PRESSURE; META ANALYSIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW;

ANIMALS; CEREBRAL ANGIOGRAPHY; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HUMANS; MACACA; MALE; MICE; PUBLICATION BIAS; RABBITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; SPECIES SPECIFICITY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84865972562     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.57     Document Type: Review

References (88)

1. Bilginer B, Onal MB, Narin F, Soylemezoglu F, Ziyal IM, Ozgen T (2009) The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. Turk Neurosurg 19:374-9
2. Bulsara KR, Coates JR, Agrawal VK, Eifler DM, Wagner-Mann CC, Durham HE, Fine DM, Toft K (2006) Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg Focus 21:E11
3. Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS (1996) Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 85:917-22 (Pubitemid 26362158)
4. Chang CZ,Wu SC, Lin CL, Hwang SL, Howng SL, Kwan AL (2010) Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats. Acta Neurochir (Wien) 152:1399-406
5. Chen G, Zhang S, Shi J, Ai J, Hang C (2009) Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage. Cytokine 45:162-8
6. Cheng G, Wei L, Zhi-Dan S, Shi-Guang Z, Xiang-Zhen L (2009) Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. BMC Neurosci 10:7
7. Chung WY, Lee LS (1993) The effect of tissue plasminogen activator (t-PA) on cerebral vasospasm in canine subarachnoid hemorrhage. Chung Hua i Hsueh Tsa Chih 52:298-306
8. Cosentino F, McMahon EG, Carter JS, Katusic ZS (1993) Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22(Suppl 8):S332-5 (Pubitemid 24027961)
9. Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2011) Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42:919-23
10. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl U, Bohner G, Strong AJ (2009) Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132:1866-81
11. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D (1984) A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: clinical and radiological findings. J Neurosurg 60: 1167-1175 (Pubitemid 14108236)
12. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31:1443-51
13. Fergusen S, Macdonald RL (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658-67 (Pubitemid 46581089)
14. Findlay JM, Weir BK, Gordon P, Grace M, Baughman R (1989) Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 24:491-8 (Pubitemid 19094781)
15. Findlay JM, Weir BK, Kanamaru K, Grace M, Baughman R (1990) The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 26:201-6 (Pubitemid 20091241)
16. Findlay JM, Weir BK, Steinke D, Tanabe T, Gordon P, Grace M (1988) Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:723-35
17. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De VG, Piedimonte G, Salpietro FM, Tomasello F (2002) Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 99:5627-31 (Pubitemid 34411600)
18. Gul S, Bahadir B, Hanci V, Acikgoz S, Bektas S, Ugurbas E, Ankarali H, Kalayci M, Acikgoz B (2010) Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats. J Clin Neurosci 17:608-11
19. Hanggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Nawatny J, Turowski B, Sommer C, Steiger HJ (2009) Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. Neurosurgery 64:1155-9
20. Hariton GB, Findlay JM, Weir BK, Kasuya H, Grace MG, Mielke BW (1993) Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery 33:691-6
21. Higgins J, Green S (2008) Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration Available at http://www. cochranehandbook.org
22. Hino A, Weir BK, Macdonald RL, Thisted RA, Kim CJ, Johns LM (1995) Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503-9
23. Itoh S, Sasaki T, Asai A, Kuchino Y (1994) Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 81:759-64 (Pubitemid 24328704)
24. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M (1993) A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Comm 195:969-75 (Pubitemid 23280510)
25. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, Macdonald RL (2009) Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci 10:103
26. Josko J, Hendryk S, Jedrzejowska-Szypulka H, Slowinski J, Gwozdz B, Lange D, Harabin-Slowinska M (2000) Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. J Physiol Pharmacol 51:241-9 (Pubitemid 30436073)
27. Kanamaru K, Weir BK, Findlay JM, Grace M, Macdonald RL (1990) A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model. Neurosurgery 27:29-38 (Pubitemid 20226079)
28. Kanamaru K, Weir BK, Simpson I, Witbeck T, Grace M (1991) Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 74: 454-459
29. Kawada S, Kinugasa K, Meguro T, Hirotsune N, Tokunaga K, Kamata I, Nakashima H, Ohmoto T (1999) Experimental study of intracisternal administration of tissuetype plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir 141:1331-8 (Pubitemid 30042881)
30. Kawashima A, Kasuya H, Sasahara A, Miyajima M, Izawa M, Hori T (2000) Prevention of cerebral vasospasm by nicardipine prolonged-release implants in dogs. Neurol Res 22:634-41
31. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM (1996) Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Stroke 27:1629-33 (Pubitemid 26295916)
32. Kim I, Leinweber BD, Morgalla M, Butler WE, Seto M, Sasaki Y, Peterson JW, Morgan KG (2000) Thin and thick filament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 46:440-7 (Pubitemid 30094482)
33. Kita T, Kubo K, Hiramatsu K, Sakaki T, Yonetani Y, Sato S, Fujimoto M, Nakashima T (1998) Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model. Life Sci 63:305-15 (Pubitemid 28302473)
34. Kwan AL, Bavbek M, Jeng AY, ManiaraW, Toyoda T, Lappe RW, Kassell NF, Lee KS (1997) Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg 87:281-6 (Pubitemid 27349115)
35. Kwan AL, Lin CL, Chang CZ, Wu HJ, Hwong SL, Jeng AY, Lee KS (2001) Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 49:422-7
36. Kwan AL, Lin CL, Yen CP, Winardi W, Su YF, Winardi D, Dai ZK, Jeng AY, Kassell NF, Howng SL, Wang CJ (2006) Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage. Exp Biol Med (Maywood) 231:1069-74 (Pubitemid 43845580)
37. Laslo AM, Eastwood JD, Chen FX, Lee TY (2006) Dynamic CT perfusion imaging in subarachnoid hemorrhagerelated vasospasm. AJNR 27:624-31 (Pubitemid 44897788)
38. Lewis PJ, Weir BK, Nosko MG, Tanabe T, Grace MG (1988) Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 22:492-500 (Pubitemid 18095951)
39. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
40. Lin CL, Kwan AL, Dumont AS, Su YF, Kassell NF, Wang CJ, Wu SC, Kuo CL, Huang CS, Jeng AY, Liu CS (2007) Attenuation of experimental subarachnoid hemorrhageinduced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelinconverting enzyme inhibitor CGS 26303. J Neurosurg 106:442-8 (Pubitemid 46354298)
41. Macdonald RL (2011) Predicting vasospasm after subarachnoid hemorrhage. World Neurosurg 75:25-6
42. Macdonald RL, Bassiouny M, Johns L, Sajdak M, Marton LS, Weir BK, Hall ED, Andrus PK (1998a) U74389G prevents vasospasm after subarachnoid hemorrhage in dogs. Neurosurgery 42:1339-45
43. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R (2004) Magnesium and experimental vasospasm. J Neurosurg 100:106-10 (Pubitemid 38017822)
44. Macdonald RL, Johns L, Lin G, Marton LS, Hallak H, Marcoux F, Kowalczuk A (1998b) Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707. Neurologia Medico-Chirurgica 38(Suppl):138-45 (Pubitemid 28551374)
45. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015-21
46. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J (2008) Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med 34:932-8 (Pubitemid 351571198)
47. Matsui T, Asano T (1994) Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a 00two-hemorrhage00 model of beagle dogs. Neurosurgery 34:1035-9 (Pubitemid 24174244)
48. Matsumura Y, Ikegawa R, Suzuki Y, Takaoka M, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe M, Morimoto S (1991) Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49:841-8
49. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner DS (2002) Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33:2950-6 (Pubitemid 35462871)
50. McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE (2006) Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58:945-51
51. Megyesi JF, Vollrath B, Cook DA, Findlay JM (2000) In vivo animal models of cerebral vasospasm: a review. Neurosurgery 46:448-60
52. Mesis RG, Wang H, Lombard FW, Yates R, Vitek MP, Borel CO, Warner DS, Laskowitz DT (2006) Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus 21:E4
53. Mignini LE, Khan KS (2006) Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research. BMC Med Res Methodol 6:10
54. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
55. Murphy AM, Xenocostas A, Pakkiri P, Lee TY (2008) Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model. J Neurosurg 109:1155-64
56. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635-42
57. Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T (1993) An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-74
58. Nosko M, Weir B, Krueger C, Cook D, Norris S, Overton T, Boisvert D (1985) Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 16:129-36 (Pubitemid 15170822)
59. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM (1999) Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90:1105-14 (Pubitemid 29241180)
60. Pasqualin A, Vollmer DG, Marron JA, Tsukahara T, Kassell NF, Torner JC (1991) The effect of nicardipine on vasospasm in rabbit basilar artery after subarachnoid hemorrhage. Neurosurgery 29:183-8
61. Roux S, Breu V, Giller T, Neidhart W, Ramuz H, Coassolo P, Clozel JP, Clozel M (1997) Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther 283:1110-8 (Pubitemid 28016483)
62. Santhanam AV, Smith LA, Akiyama M, Rosales AG, Bailey KR, Katusic ZS (2005) Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36:2731-7
63. Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, Sugita K, Hidaka H (1992) Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm. Eur J Pharmacol 220:243-8
64. Seifert V, Eisert WG, Stolke D, Goetz C (1989) Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage [see comments]. Neurosurgery 25:590-8 (Pubitemid 19236265)
65. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR (2010) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8:e1000344
66. Shigeno T, Clozel M, Sakai S, Saito A, Goto K (1995) The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 37:87-90
67. Steinke DE, Weir BK, Findlay JM, Tanabe T, Grace M, Krushelnycky BW (1989) A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-86 (Pubitemid 19044581)
68. Sugawara T, Ayer R, Jadhav V, Chen W, Tsubokawa T, Zhang JH (2008) Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 86:3635-43
69. Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T (1998) Effects of unilateral intrathecal administrations of low dose tissue-type plasminogen activator on clot lysis, vasospasm and brain phospholipid hydroperoxidation in a primate model of bilateral subarachnoid hemorrhage. Neurol Res 20:625-31 (Pubitemid 28440010)
70. Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T (1999) Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage. Stroke 30:450-5
71. Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH (2001a) Intrathecal application with liposomeentrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci 8: 557-561 (Pubitemid 33089508)
72. Takanashi Y, Ishida T, Meguro T, Kiwada H, Zhang JH, Yamamoto I (2001b) Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 48:894-900
73. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW (2008) Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol 213:336-44
74. Tang WH, Chen Z, Liu Z, Zhang JH, Xi G, Feng H (2008) The effect of ecdysterone on cerebral vasospasm following experimental subarachnoid hemorrhage in vitro and in vivo. Neurol Res 30:571-80 (Pubitemid 352032553)
75. Titova E, Ostrowski RP, Zhang JH, Tang J (2009) Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res 31:568-81
76. Turowski B, Hanggi D, Beck A, Aurich V, Steiger HJ, Moedder U (2007) New angiographic measurement tool for analysis of small cerebral vessels: application to a subarachnoid haemorrhage model in the rat. Neuroradiology 49:129-37 (Pubitemid 46218585)
77. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 7:e1000245
78. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB (2008) Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761-70
79. Vollmer DG, Kassell NF, Hongo K, Ogawa H, Tsukahara T (1989) Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm. Surg Neurol 31:190-4 (Pubitemid 19086117)
80. Wanebo JE, Arthur AS, Louis HG, West K, Kassell NF, Lee KS, Helm GA (1998) Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery 43:1409-17
81. Wanebo JE, Louis HG, Arthur AS, Zhou J, Kassell NF, Lee KS, Helm GA (1997) Attenuation of cerebral vasospasm by systemic administration of an endothelin-A receptor antagonist, TBC 11251, in a rabbit model of subarachnoid hemorrhage. Neurosurg Focus 3: E8
82. Wang Z, Chen G, Zhu WW, Bian JY, Shen XO, Zhou D (2010) Influence of simvastatin on microthrombosis in the brain after subarachnoid hemorrhage in rats: a preliminary study. Ann Clin Lab Sci 40:32-42
83. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC (1994) Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25:2450-5
84. Zabramski J, Spetzler RF, Bonstelle C (1986) Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery 18:129-35 (Pubitemid 16161272)
85. Zimmermann M, Seifert V, Loffler BM, Stolke D, Stenzel W (1996) Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery 38:115-20 (Pubitemid 26002390)
86. Zuccarello M, Boccaletti R, Romano A, Rapoport RM (1998) Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924-9 (Pubitemid 28399991)
87. Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK (1989) Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 71:98-104 (Pubitemid 19196559)
88. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM (1996) Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 84:503-7 (Pubitemid 26064559)